[{"address1": "221 Crescent Street", "address2": "Building 17 Suite 102b", "city": "Waltham", "state": "MA", "zip": "02453", "country": "United States", "phone": "650 394 5230", "website": "https://www.apogeetherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), asthma, chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company primarily develops APG777, a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for AD; and APG808, an SQ extended half-life mAb for COPD. Its earlier-stage programs comprise APG990, an SQ extended half-life mAb for the treatment of AD; and APG222, an extended half-life SQ antibodies for AD. Apogee Therapeutics, Inc. was incorporated in 2022 and is headquartered in Waltham, Massachusetts.", "fullTimeEmployees": 91, "companyOfficers": [{"maxAge": 1, "name": "Dr. Michael Thomas Henderson M.D.", "age": 34, "title": "CEO & Director", "yearBorn": 1990, "fiscalYear": 2023, "totalPay": 1171208, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jane Pritchett V. Henderson", "age": 58, "title": "Chief Financial Officer", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 843643, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Carl Linden Dambkowski M.D.", "age": 39, "title": "Chief Medical Officer", "yearBorn": 1985, "fiscalYear": 2023, "totalPay": 870833, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Noel  Kurdi", "title": "Vice President of Investor Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Matthew  Batters J.D.", "age": 48, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1976, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Emily  Cox", "title": "VP & Head of People", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Rebecca  Dabora Ph.D.", "age": 64, "title": "Chief Development Officer", "yearBorn": 1960, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Wendy  Aspden-Curran", "title": "Senior Vice President of Clinical Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Drew  Badger Ph.D.", "title": "Senior VP and Head of Regulatory Affairs & Toxicology", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Monica  Forbes", "age": 48, "title": "Senior Vice President of Finance", "yearBorn": 1976, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 6, "compensationRisk": 9, "shareHolderRightsRisk": 10, "overallRisk": 9, "governanceEpochDate": 1738368000, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 33.95, "open": 34.59, "dayLow": 32.54, "dayHigh": 34.95, "regularMarketPreviousClose": 33.95, "regularMarketOpen": 34.59, "regularMarketDayLow": 32.54, "regularMarketDayHigh": 34.95, "payoutRatio": 0.0, "forwardPE": -9.092105, "volume": 643219, "regularMarketVolume": 643219, "averageVolume": 538874, "averageVolume10days": 577690, "averageDailyVolume10Day": 577690, "bid": 34.21, "ask": 34.78, "bidSize": 1, "askSize": 2, "marketCap": 1965995136, "fiftyTwoWeekLow": 32.46, "fiftyTwoWeekHigh": 72.29, "fiftyDayAverage": 42.5374, "twoHundredDayAverage": 47.246723, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1417944832, "profitMargins": 0.0, "floatShares": 37879129, "sharesOutstanding": 43416300, "sharesShort": 8831060, "sharesShortPriorMonth": 8087434, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.1552, "heldPercentInsiders": 0.116409995, "heldPercentInstitutions": 1.3270199, "shortRatio": 16.92, "shortPercentOfFloat": 0.2283, "impliedSharesOutstanding": 56902900, "bookValue": 12.907, "priceToBook": 2.676842, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -146663008, "trailingEps": -2.43, "forwardEps": -3.8, "52WeekChange": -0.027499259, "SandP52WeekChange": 0.2021538, "quoteType": "EQUITY", "currentPrice": 34.55, "targetHighPrice": 110.0, "targetLowPrice": 80.0, "targetMeanPrice": 92.28571, "targetMedianPrice": 90.0, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 7, "totalCash": 526048992, "totalCashPerShare": 9.245, "totalDebt": 12140000, "quickRatio": 16.277, "currentRatio": 16.39, "debtToEquity": 1.653, "returnOnAssets": -0.18515, "returnOnEquity": -0.25648, "freeCashflow": -86914000, "operatingCashflow": -133214000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "APGE", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Apogee Therapeutics, Inc.", "longName": "Apogee Therapeutics, Inc.", "corporateActions": [], "postMarketTime": 1740171903, "regularMarketTime": 1740171600, "fiftyDayAverageChange": -7.9874, "fiftyDayAverageChangePercent": -0.18777359, "twoHundredDayAverageChange": -12.696724, "twoHundredDayAverageChangePercent": -0.26873237, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2023-07-14", "averageAnalystRating": "1.0 - Strong Buy", "cryptoTradeable": false, "marketState": "POST", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1689341400000, "postMarketChangePercent": 0.0, "postMarketPrice": 34.55, "postMarketChange": 0.0, "regularMarketChange": 0.5999985, "regularMarketDayRange": "32.54 - 34.95", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 538874, "fiftyTwoWeekLowChange": 2.0900002, "fiftyTwoWeekLowChangePercent": 0.06438694, "fiftyTwoWeekRange": "32.46 - 72.29", "fiftyTwoWeekHighChange": -37.74, "fiftyTwoWeekHighChangePercent": -0.5220639, "fiftyTwoWeekChangePercent": -2.7499259, "earningsTimestampStart": 1741008600, "earningsTimestampEnd": 1741354200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -2.43, "epsForward": -3.8, "epsCurrentYear": -3.094, "priceEpsCurrentYear": -11.166774, "exchange": "NGM", "messageBoardId": "finmb_1816591253", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 1.7673002, "regularMarketPrice": 34.55, "displayName": "Apogee Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-02-21"}]